These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8740755)

  • 41. Reanalysis of cefazolin surrogate susceptibility breakpoints utilized as guidances for oral cephalosporin treatments of uncomplicated urinary tract infections: caution concerning application to cefadroxil.
    Nguyen HM; Jones RN
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115053. PubMed ID: 32349909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Penicillin and Beta-Lactam Hypersensitivity.
    Har D; Solensky R
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):643-662. PubMed ID: 28965632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
    Park M; Markus P; Matesic D; Li JT
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):681-7. PubMed ID: 17165279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
    Dinur-Schejter Y; Cohen-Cymberknoh M; Tenenbaum A; Brooks R; Averbuch D; Kharasch S; Kerem E
    Pediatr Pulmonol; 2013 Jan; 48(1):52-8. PubMed ID: 22431471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The newer penicillins.
    Asper R; Schwartz AR
    Am Fam Physician; 1975 Jan; 11(1):134-8. PubMed ID: 162819
    [No Abstract]   [Full Text] [Related]  

  • 46. [General characteristics of polysynthetic penicillins].
    Doĭl FP
    Antibiotiki; 1971 Oct; 16(10):870-7. PubMed ID: 5003054
    [No Abstract]   [Full Text] [Related]  

  • 47. A hospital outbreak of high-level beta-lactam-resistant Enterobacter spp.: association more with ampicillin and cephalosporin therapy than with nosocomial transmission.
    Walder M; Haeggman S; Tullus K; Burman LG
    Scand J Infect Dis; 1996; 28(3):293-6. PubMed ID: 8863365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    Azimi PH; Barson WJ; Janner D; Swanson R
    Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of antibiotics. Cephalosporins.
    Wise R
    Br Med J; 1978 Jul; 2(6129):40-2. PubMed ID: 678801
    [No Abstract]   [Full Text] [Related]  

  • 50. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
    Goldstein FW
    Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children.
    Casey JR; Pichichero ME
    Pediatrics; 2004 Apr; 113(4):866-82. PubMed ID: 15060239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of cefuroxime as an alternative in patients with a proven hypersensitivity to penicillins: a DAHD cohort survey.
    Caimmi S; Galéra C; Bousquet-Rouanet L; Arnoux B; Demoly P; Bousquet PJ
    Int Arch Allergy Immunol; 2010; 153(1):53-60. PubMed ID: 20357485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia.
    Batard E; Lecadet N; Goffinet N; Hardouin JB; ; Lepelletier D; Potel G; Montassier E
    Infection; 2015 Dec; 43(6):681-9. PubMed ID: 25998004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cephalosporin antibiotics in pediatric practice.
    Ross S; Rodriguez W; Khan W
    South Med J; 1977 Jul; 70(7):855-61. PubMed ID: 877649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection.
    Kernodle DS; Voladri RK; Kaiser AB
    J Infect Dis; 1998 Mar; 177(3):701-6. PubMed ID: 9498450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial therapy for ambulatory pediatrics.
    Ogle JW
    Pediatr Ann; 1999 Jul; 28(7):434-44. PubMed ID: 10884854
    [No Abstract]   [Full Text] [Related]  

  • 58. Antimicrobial therapy in dialysis patients. I. Penicillins and cephalosporins.
    Andrassy K; Ritz E
    Blood Purif; 1985; 3(1-3):94-103. PubMed ID: 3854281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.
    Trcka J; Seitz CS; Bröcker EB; Gross GE; Trautmann A
    J Antimicrob Chemother; 2007 Jul; 60(1):107-11. PubMed ID: 17510067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delayed hypersensitivity to cefazolin: report on a case involving lymphocyte transformation studies with different cephalosporins.
    Romano A; Torres MJ; Di Fonso M; Leyva L; Andriolo M; Pettinato R; Blanca M
    Ann Allergy Asthma Immunol; 2001 Sep; 87(3):238-42. PubMed ID: 11570622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.